Gene co-expression changes underlying the functional connectomic alterations in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8794
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Gene co-expression changes underlying the functional connectomic alterations in Alzheimer’s disease ; volume:15 ; number:2 ; day:23 ; month:4 ; year:2022 ; pages:1-9 ; date:12.2022
BMC medical genomics ; 15, Heft 2 (23.4.2022), 1-9, 12.2022
- Urheber
-
He, Bing
Gorijala, Priyanka
Xie, Linhui
Cao, Sha
Yan, Jingwen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12920-022-01244-6
- URN
-
urn:nbn:de:101:1-2022070620091181571031
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- He, Bing
- Gorijala, Priyanka
- Xie, Linhui
- Cao, Sha
- Yan, Jingwen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alzheimer’s disease rewires gene coexpression networks coupling different brain regions
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease
Pathological Alterations Induced by intraneuronal Aβ in Alzheimer’s Disease
Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Genes and pathways underlying regional and cell type changes in Alzheimer's disease
Systemic and central nervous system metabolic alterations in Alzheimer’s disease
Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease
Functional alterations of myeloid cells during the course of Alzheimer’s disease
Alzheimer’s disease rewires gene coexpression networks coupling different brain regions
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease
Pathological Alterations Induced by intraneuronal Aβ in Alzheimer’s Disease
Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Genes and pathways underlying regional and cell type changes in Alzheimer's disease
Systemic and central nervous system metabolic alterations in Alzheimer’s disease
Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease
Functional alterations of myeloid cells during the course of Alzheimer’s disease
Alzheimer’s disease rewires gene coexpression networks coupling different brain regions
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease
Pathological Alterations Induced by intraneuronal Aβ in Alzheimer’s Disease
Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Genes and pathways underlying regional and cell type changes in Alzheimer's disease
Systemic and central nervous system metabolic alterations in Alzheimer’s disease
Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease